July 29, 2025

Similar Efficacy, Improved Safety Achieved Without Concurrent Cisplatin for Locoregionally Advanced Nasopharyngeal Cancer

The PD-1 inhibitor toripalimab in combination with an induction chemoradiotherapy regimen free of concurrent cisplatin demonstrated noninferior efficacy and superior safety compared with the same regi...

The ASCO Post

May 06, 2025

Mammograms: The Experts Share Their Thoughts

In 2025, approximately 375,000 cases of breast cancer are expected to be diagnosed in the U.S., according to the American Cancer Society.

Baptist Health South Florida

March 12, 2025

As Technology Progresses, Aneurysm Treatments Become Safer and More Reasonable to Consider

Observing the 2.4 mm aneurysm in one female patient seemed reasonable in 2013. But when the evolution of endovascular techniques and technology provided an opportunity to cure her aneurysm in 2024, the 70-year-old patient sought treatment at Mount Sinai’s Cerebrovascular Center. By then, imaging had revealed the aneurysm to be nearly 7 mm in size.

Mount Sinai New York

September 30, 2024

Fox Chase Cancer Center Researchers Show Adaptive Radiation Therapy Delivers Treatment More Effectively in Study Presented at American Society for Radiation Oncology Meeting

Online adaptive radiation therapy (ART) delivered radiation more effectively than conventional radiation therapy in nearly half of patients, while also helping to decrease radiation dose to the esophagus in a majority of patients with thoracic spine tumors. That’s according to the results of a study presented today by Fox Chase Cancer Center researchers at the American Society for Radiation Oncology (ASTRO) Annual Meeting in Washington, D.C.

Fox Chase Cancer Center

June 13, 2025

Weight Loss Drugs Show Promise for Heart Failure

ACC statement highlights semaglutide and tirzepatide as therapies associated with improved symptoms and functional capacity in patients with heart failure with preserved ejection fraction and obesity.

Conexiant

December 04, 2024

Can NST-628 Fill the Treatment Void For Advanced Tumors with RAS or RAF Mutations?

A phase 1 clinical trial underway at Roswell Park Comprehensive Cancer Center will evaluate the potential of a “molecular glue” to treat MAPK pathway-mutated advanced solid tumors in patients who have exhausted standard treatment options.

Roswell Park Comprehensive Cancer Center

June 18, 2024

New Guidelines for Radiation Therapy for HPV-associated Head and Neck Cancer

Radiation therapy for HPV-positive oropharyngeal squamous cell carcinoma: An ASTRO clinical practice guideline

Dana-Farber

December 20, 2023

Novel Artificial Intelligence Technology Shows Promising Results for Earlier and More Accurate Breast Cancer Detection

Data from the Centers for Disease Control and Prevention highlight that Breast Cancer is second most common form of cancer among women in the U.S. with approximately 240,000 new breast cancer diagnoses each year.

Baptist Health South Florida

November 14, 2023

A New Fellowship For Breast Imaging Leadership

The new fellow will spend nine months on interpreting, screening, and diagnostic procedures, learn how to perform all forms of biopsies using the most advanced techniques; and gain skills to run a breast imaging center.

Fox Chase Cancer Center